Nosocomial COVID-19: A Nationwide Spanish Study.

Aged COVID-19 Cross-infection Elderly Hospital mortality Hospital-acquired (nosocomial) infection SARS-CoV-2

Journal

Gerontology
ISSN: 1423-0003
Titre abrégé: Gerontology
Pays: Switzerland
ID NLM: 7601655

Informations de publication

Date de publication:
2023
Historique:
received: 24 11 2021
accepted: 14 09 2022
medline: 7 6 2023
pubmed: 23 1 2023
entrez: 22 1 2023
Statut: ppublish

Résumé

SARS-CoV-2 is a highly contagious virus, and despite professionals' best efforts, nosocomial COVID-19 (NC) infections have been reported. This work aimed to describe differences in symptoms and outcomes between patients with NC and community-acquired COVID-19 (CAC) and to identify risk factors for severe outcomes among NC patients. This is a nationwide, retrospective, multicenter, observational study that analyzed patients hospitalized with confirmed COVID-19 in 150 Spanish hospitals (SEMI-COVID-19 Registry) from March 1, 2020, to April 30, 2021. NC was defined as patients admitted for non-COVID-19 diseases with a positive SARS-CoV-2 test on the fifth day of hospitalization or later. The primary outcome was 30-day in-hospital mortality (IHM). The secondary outcome was other COVID-19-related complications. A multivariable logistic regression analysis was performed. Of the 23,219 patients hospitalized with COVID-19, 1,104 (4.8%) were NC. Compared to CAC patients, NC patients were older (median 76 vs. 69 years; p < 0.001), had more comorbidities (median Charlson Comorbidity Index 5 vs. 3; p < 0.001), were less symptomatic (p < 0.001), and had normal chest X-rays more frequently (30.8% vs. 12.5%, p < 0.001). After adjusting for sex, age, dependence, COVID-19 wave, and comorbidities, NC was associated with lower risk of moderate/severe acute respiratory distress syndrome (ARDS) (adjusted odds ratio [aOR]: 0.72; 95% confidence interval [CI]: 0.59-0.87; p < 0.001) and higher risk of acute heart failure (aOR: 1.40; 1.12-1.72; p = 0.003), sepsis (aOR: 1.73; 1.33-2.54; p < 0.001), and readmission (aOR: 1.35; 1.03-1.83; p = 0.028). NC was associated with a higher case fatality rate (39.1% vs. 19.2%) in all age groups. IHM was significantly higher among NC patients (aOR: 2.07; 1.81-2.68; p < 0.001). Risk factors for increased IHM in NC patients were age, moderate/severe dependence, malignancy, dyspnea, moderate/severe ARDS, multiple organ dysfunction syndrome, and shock; odynophagia was associated with lower IHM. NC is associated with greater mortality and complications compared to CAC. Hospital strategies to prevent NC must be strengthened.

Identifiants

pubmed: 36682355
pii: 000527711
doi: 10.1159/000527711
pmc: PMC9893008
doi:

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

671-683

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Jose-Manuel Ramos-Rincon (JM)

Clinical Medicine Department, Miguel Hernandez University of Elche, Alicante, Spain.

Almudena Lopez-Sampalo (A)

Internal Medicine Department, Regional University Hospital of Málaga and Biomedical Research Institute of Málaga (IBIMA), and University of Málaga (UMA), Málaga, Spain.

Lidia Cobos-Palacios (L)

Internal Medicine Department, Regional University Hospital of Málaga and Biomedical Research Institute of Málaga (IBIMA), and University of Málaga (UMA), Málaga, Spain.

Michele Ricci (M)

Internal Medicine Department, Regional University Hospital of Málaga and Biomedical Research Institute of Málaga (IBIMA), and University of Málaga (UMA), Málaga, Spain.

Manel Rubio-Rivas (M)

Internal Medicine Department, Bellvitge University Hospital- -IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Raquel Díaz-Simón (R)

Internal Medicine Department, 12 Octubre University Hospital, Madrid, Spain.

María-Dolores Martín-Escalante (MD)

Internal Medicine Department, Costa del Sol Hospital, Marbella, Spain.

Sabela Castañeda-Pérez (S)

Internal Medicine Department, Internal Medicine Department, Gregorio Marañon University Hospital, Madrid, Spain.

Rosa Fernández-Madera-Martínez (R)

Internal Medicine Department, Cabueñes University Hospital, Gijón, Spain.

Jose-Luis Beato-Perez (JL)

Internal Medicine Department, Albacete University Hospital Complex, Albacete, Spain.

Gema-Maria García-García (GM)

Internal Medicine Department, Badajoz University Hospital Complex, Badajoz, Spain.

María-Del-Mar García-Andreu (MD)

Internal Medicine Department, Royo Villanova Hospital, Zaragoza, Spain.

Francisco Arnalich-Fernandez (F)

Internal Medicine Department, La Paz University Hospital, Madrid, Spain.

Sonia Molinos-Castro (S)

Internal Medicine Department, Santiago de Compostela Clinic Hospital, Santiago de Compostela, A Coruña, Spain.

Juan-Antonio Vargas-Núñez (JA)

Internal Medicine Department, Puerta de Hierro University Hospital, Madrid, Spain.

Arturo Artero (A)

Internal Medicine Department, Dr. Peset University Hospital, Valencia, Spain.

Santiago-Jesús Freire-Castro (SJ)

Internal Medicine Department, A Coruña University Hospital, A Coruña, Spain.

Jennifer Fernández-Gómez (J)

Internal Medicine Department, Elda General University Hospital, Alicante, Spain.

Pilar Cubo-Romano (P)

Internal Medicine Department, Infanta Cristina University Hospital, Madrid, Spain.

Almudena Hernández-Milián (A)

Internal Medicine Department, Son Llàtzer University Hospital, Palma de Mallorca, Spain.

Sandra-Maria Inés-Revuelta (SM)

Internal Medicine Department, Salamanca University Assistance Complex, Salamanca, Spain.

Ramon Boixeda (R)

Internal Medicine Department, Mataró Hospital, Barcelona, Spain.

Elia Fernández-Pedregal (E)

Internal Medicine Department, Germans Trias I Pujol University Hospital, Barcelona, Spain.

Ricardo Gómez-Huelgas (R)

Internal Medicine Department, Regional University Hospital of Málaga and Biomedical Research Institute of Málaga (IBIMA), and University of Málaga (UMA), Málaga, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH